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Acute Hepatopancreatic Necrosis Disease (AHPND) causes more than a billion 
dollars of losses to the shrimp farming industry annually.  In 2013, strains of the 
marine pathogen Vibrio parahaemolyticus containing genes for the PirAVp/BVp toxins, 
encoded on a 70 Kb plasmid, were identified as the causative agent of AHPND.  
Antibiotics have been used to attempt to reduce losses, however their use in 
aquaculture is controversial.  Additionally, the pathogen has demonstrated the ability 
to rapidly acquire antibiotic resistances through genetic mutation and lateral gene 
transfer.  Probiotics, often used to prevent disease in aquaculture, may offer the 
opportunity to mitigate AHPND infections without the risks to consumers and the 
environment posed by antibiotic use.  The goal of this study was to determine if the 
marine probiont Phaeobacter inhibens S4 protects Litopenaeus vannamei post-larvae 
(PLs) against fatal V. parahaemolyticus infections and to elucidate its protective 
mechanisms.  A further goal of this study was to isolate and identify other potential 
probionts, including “Bdellovibrio and Like Organisms” (BALO), whose prey range 
includes V. parahaemolyticus.  
P. inhibens S4 was tested in challenge assays using Artemia nauplii and L. 
vannamei for its ability to protect these organisms from V. parahaemolyticus-induced 
mortality.  Zhao et al previously identified three key probiotic activities of P. inhibens 
S4: 1) the production of the antibiotic compound tropodithietic acid (TDA), 2) the 
formation of a copious biofilm, and 3) quorum sensing/quorum quenching activity 
through N-acyl homoserine lactone (AHL) signaling.  Mutant strains of P. inhibens S4 
 
 
with one or a combination of these three mechanisms altered were used in PL 
challenge assays to asses which probiotic functions were key to protecting shrimp.  
Competition assays, to assess in vitro growth of V. parahaemolyticus PSU5579 when 
co-cultured with P. inhibens S4 or one of the mutant strains, were also performed to 
determine the ability of S4 to inhibit the growth of the pathogen in biofilms and 
planktonic states.  Results showed that P. inhibens S4SmKm protects L. vannamei PLs 
from AHPND, increasing survival from 45% in the infected control to 80% when the 
environment is pre-treated with P. inhibens S4SmKm.  Assays with wild type and 
mutant strains of P. inhibens show protection whether or not TDA is produced; 
however, S4 no longer protects when biofilm production is reduced or quorum 
sensing/quorum quenching is disrupted. In support of these results, it was shown 
that P. inhibens S4 does not inhibit the growth of V. parahaemolyticus when co-
cultured, nor is V. parahaemolyticus sensitive to the antibiotic TDA, even up to 
concentrations of 100 µg/ml.   
To screen for other potential probionts and a BALO organism, bacteria 
isolated from seawater and shrimp tank water were screened using a zones of 
inhibition (ZOI) assay and for plaque forming capabilities in lawns of V. 
parahaemolyticus.  A candidate BALO was isolated from Narragansett Bay that 
showed predatory activity against V. parahaemolyticus. Genomic DNA was extracted, 
and the genome was sequenced. The organism appears to be a previously 
unidentified species of Halobacteriovorax, given the strain name GB3. While 
Halobacteriovorax GB3 does not harm L. vannamei PLs, we did not test its ability to 
 
 
protect shrimp from AHPND because it does not reduce V. parahaemolyticus 
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The following thesis has been prepared in manuscript format according to the 
guidelines of the Graduate School of the University of Rhode Island.  This thesis 
contains a literature review and two manuscripts. 
The first manuscript “Investigating the probiotic activities of Phaeobacter 
Inhibens S4 against AHPND-inducing Vibrio parahaemolyticus” will be submitted to 
Applied and Environmental Microbiology. 
The second manuscript “Draft Genome Sequence of Halobacteriovorax  sp. 
Strain GB3, a  Predatory Bacterium Isolated from Narragansett Bay that Preys on 
Shrimp Pathogen Vibrio parahaemolyticus PSU5579” will be submitted to 
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REVIEW OF LITERATURE 
 
Statement of the problem  
Shrimp aquaculture is a multi-billion dollar global industry with production 
estimated between 2.9-3.5 billion tons in 2017 with 75-80% of production originating 
in South East Asia (1).  In the United States alone, shrimp imports in 2017 were worth 
$6.5 billion, an increase of 14% from the year before (1). Acute Hepatopancreatic 
Necrosis Disease (AHPND) is the major cause of Early Mortality Syndrome (EMS), 
responsible for significant losses in the shrimp farming industry. EMS emerged in 
2009 affecting shrimp farms in southern China, causing up to 100% mortality in 
shrimp ponds within 30 days (2).  The disease in shrimp is characterized by a pale and 
atrophied hepatopancreas and an empty gut (3). By 2014, AHPND had spread to 
Vietnam, Malaysia, Thailand, Mexico and the Philippines (2). The primary cause of 
AHPND has been has been identified as strains of Vibrio parahaemolyticus that 
produce PirA and PirB toxins (encoded by pirA and pirB, respectively) and contain an 
antibacterial Type VI secretion system (T6SS) (3). Utilizing antibiotics to control 
AHPND has not been a successful strategy (4). Multi-antibiotic resistant strains of V. 
parahaemolyticus have been isolated from shrimp farms world-wide (5).  
Additionally, there is public health concern about the rise of antibiotic resistant 
organisms. Many bacteria, including V. parahaemolyticus, acquire and transfer new 
antibiotic resistances through lateral gene transfer (6), demonstrating the dangers of 




shrimp lack an acquired immune system, posing challenges to vaccine 
development.   Probiotics, defined as “live microorganisms, conferring a healthy 
benefit on the host when being consumed in adequate amounts” (7) are becoming a 
preferred method to prevent bacterial infections in aquaculture (8). Recent data 
indicate that Phaeobacter inhibens S4Sm, which has shown significant inhibitory 
activity against other Vibrio species such as of Vibrio anguillarum and Vibrio 
coralliilyticus RE22 (9) (10) 11), also has potential as a probiotic treatment in shrimp 
aquaculture to prevent AHPND (12).  In addition to P. inhibens, we have isolated and 
investigated two other bacterial strains: Pseudoalteromonas piscicida JC3, which has 
recently been shown to inhibit the growth of multiple Vibrio species including V. 
parahaemolyticus (13), and a previously unidentified member of the BALO genus, 
Halobacteriovorax strain GB3. 
 
Background on shrimp farming 
 
Aquaculture is the world’s fastest growing food production sector with an 
average annual growth rate of 8% (14).  Shrimp, second only to salmon and trout, 
accounted for 17% of the global trade in aquaculture species by value in 2017 
(approximately $6 billion) (15).  While shrimp farming has been a traditional means 
of growing food for thousands of years, the rise of large-scale farming for export 
began in the 1980s, driven by high demand and prices in the United States and Japan 
(14).  The rapid rise in shrimp farming has had significant impacts on the coastal 
landscapes, especially in South East Asia, with the destruction of salt flats, coastal 




farming shrimp due to its value as a crop (16).  Farming practices vary widely both 
regionally and within a given region, but shrimp ponds are either closed systems into 
which water is pumped and then pumped off when the ponds are emptied, or open 
systems which exchange water at some interval, up to 20% daily (17).  Effluent from 
shrimp ponds degrades the water quality in the surrounding areas by adding 
suspended solids, nutrients, and organic matter, contributing to eutrophication of 
coastal waters (16).  Outbreaks of disease in these ponds often lead to massive crop 
losses.  Around the turn of the 21st century, hatcheries began captive breeding 
programs with Litopenaeus vannamei (whiteleg shrimp) to produce Specific Pathogen 
Free (SPF), Specific Pathogen Resistant (SPR), and Specific Pathogen Tolerant (SPT) 
brood stock.  As a result, white leg shrimp are now the most commonly farmed  
species of shrimp (14).  Ponds are stocked with Post Larval Shrimp (PLs), which are 
then harvested when mature.   
 
Rise and spread of AHPND 
Originally named Early Mortality Syndrome, AHPND was first reported in 
China in 2009. By 2011 it had spread to Malaysia and Vietnam and in 2012 to 
Thailand.  The causative agent was isolated in 2013 (18), also in 2013 AHPND was 
confirmed  in Mexico (19). Clinical appearance includes a pale to white 
hepatopancreas (HP), reduced HP size, empty stomach (ST), and empty midgut (MG) 




as was seen in Thailand where production peaked in 2012 and decreased sharply 
with the emergence of AHPND (Fig 2). 
 
 Figure 1. Characteristics of AHPND.  A and B show signs of disease post challenge 
with V. parahaemolyticus including atrophied, pale HP, empty ST and empty MG.  C 
and D are examples of healthy shrimp. (18) 
 
 
Figure 2: Farmed shrimp production in Thailand from 1970-2015.  The steep decline 
in production between 2010 and 2015 coincides with the emergence of AHPND in 






Vibrio parahaemolyticus as pathogen 
V. parahaemolyticus is also known as a human pathogen; however, there are 
key differences between the strains that cause gastroenteritis in humans and those 
causing AHPND in shrimp. V. parahaemolyticus has two type six secretion systems 
(T6SS1 and T6SS2) located on chromosome one and two, respectively.  T6SS1 is most 
active in high salinity conditions and appears to target bacteria, whereas T6SS2 is 
active in low salinity, such as inside the guts of host organisms (20).  The antibacterial 
T6SS1, when activated by the high salinity of shrimp ponds, gives V. 
parahaemolyticus a competitive advantage as it is able to attack and kill other 
bacteria competing to fill niches in these aquatic environments.  Additionally, strains 
pathogenic to shrimp contain a Type Three Secretion System 1 (T3SS1), but lack a 
T3SS2, which is present in all human clinical strains and considered an important 
factor for human virulence (21).  Further, V. parahaemolyticus strains pathogenic to 
humans contain the thermostable direct hemolysin (tdh) and tdh-related hemolysin 




The PirAVp/BVp toxins are encoded on a highly conserved 70 Kb plasmid and 
flanked by transposases. It has been described as a “selfish plasmid” (3) because the 
plasmid also encodes for conjugative transfer gene clusters and a post-segregational 




are those that enhance their own transmission without necessarily conferring a 
benefit to the individual (25); the conjugative transfer gene cluster increases the 
likelihood of transfer (24). The PSK ensures that any bacterial progeny without the 
plasmid will die; this system encodes for a highly stable antibacterial mRNA which 
persists following cell division, along with a less stable and complementary antisense 
RNA which quickly degrades so that cells without the plasmid-based PSK are killed by 
the antibacterial mRNA (26). It is well documented that lateral gene transfer occurs 
among Vibrio species of the same clade, so it is not surprising to note that this 
plasmid has also been isolated from other members of the V. harveyi clade including 
Vibrio campbelli and Vibrio owensii (23, 27, 28) (Fig. 4). However, it is notable that 
the plasmid has also been isolated from more distantly related species and the 
pirAVp/BVp genes have also been observed in Micrococcus luteus strains isolated in 
Mexico (29).  
  
Figure 3.  Genetic map of the 70 Kb AHPND associated plasmid. The genetic 
elements of the plasmid include pirAvp/pirBvp flanked by transposases as well as a 




PSK associated pndA gene enhance the transfer of the plasmid and ensure its 





Figure 4. Sequence map and identity plot of AHPND associated plasmid extracted 
from V. owensii.  Mapping shows greater than 99% identity with AHPND associated 
plasmids extracted from V. parahaemolyticus (blue) and V. harveyi (green) when 
compared to the reference sequence from V. owensii (grey) demonstrating that the 
plasmid is highly conserved across species. Used with permission.(23) 
 
 
Issues with antibiotics 
The use of antibiotics in aquaculture is widespread and problematic for many 
reasons.  Residual antibiotics linger in the environment, altering microflora and 
selecting for antibiotic-resistant bacteria (30). There is a potential for human harm as 
well since residual antibiotics have been observed on aquaculture products from 
China, including shrimp.  Though not well studied as a side effect of antibiotic use in 
aquaculture, one potential risk to humans includes allergic reactions (31).  The 
greatest threat, however, to human populations is likely the rise in antibiotic 
resistance.  The data suggest that there is a strong link between the use of antibiotics 
in aquaculture and the increased frequency of drug resistant strains of pathogenic 
bacteria (32).  Furthermore, the use of fluoroquinolones has become increasingly 
common in aquaculture. Unfortunately, this class of antibiotics which do not readily 
biodegrade, also accumulate in the tissues of farmed aquatic species (32) increasing 
the potential for human adverse reaction and antibiotic resistance to a class of drugs 








Other novel therapies 
One central dogma of evolutionary immunology is that shrimp, as 
invertebrates, lack a true adaptive immune system (34).  However, research over the 
past two decades has demonstrated that shrimp can develop an immune “memory” 
or response to immune priming to both viral and bacterial pathogens following 
vaccination and other exposure to pathogens (34–37); however, it is important to 
note that V. parahaemolyticus does not appear to colonize the shrimp gut, and 
therefore vaccination or similar immune stimulus to the pathogen is not likely to 
increase survival. Recent studies have shown an ability to stimulate increased 
immune response to protect shrimp from AHPND through non-lethal heat shock, 
which upregulates heat shock proteins (38, 39), and through passive “vaccination” 
with feed-base exposure to the PirA toxin by adding anti-PirA-toxin immunoglobulin 
(IgY) from chicken egg yolk to feed (40) that render the shrimp less susceptible to the 
toxin itself.  Another emerging area of research in control of bacterial illness is 
bacteriophage therapy, which is the application of bacteriophage viruses that infect 
and kill the pathogenic bacteria without harm to the host organism.  There are many 
challenges to utilizing this treatment method, and phage therapy would be 
ineffective as a therapy for AHPND for two reasons.  First, the viruses are species 
specific and sometimes strain specific, so as the pirAvp/pirBvp genes continue to be 
transferred to other Vibrio species, this treatment will become increasingly 
ineffective.  Second, bacteria evolve resistance to phages quickly, and some strains of 




The application of bacteriophage may initially be an effective means to slow or stop 
some infections; however, repeated use will increasingly select for phage resistant 
strains of V. parahaemolyticus, requiring an ongoing search for new phage strains 
and rendering this therapy inefficient for long-term application. 
 
Probiotics in aquaculture  
Investigations into the use of probiotics in aquaculture date back to the 
1980’s (42). In aquaculture, probiotics may be applied and interact differently than in 
other systems.  They may be administered with feed or applied directly to the water.  
In addition to inhibiting pathogen growth through the production antibiotic 
compounds, probiotics can limit pathogen growth by competing for nutrients (Fig. 5) 
(43).  Probiotics can also protect host organisms by stimulating innate immune 
response and enhancing disease resistance, as multiple Bacillus species have been 





Figure 5. The applications and benefits of probiotics in shrimp aquaculture. 
Probiotics can be applied directly to the environment or in feed-based supplements.  





Phaeobacter inhibens S4Sm 
 
P. inhibens S4Sm, isolated from a healthy oyster (10) is a Gram negative, 
motile rod-shaped marine member of the Roseobacter clade of Alphaproteobacteria 
(46).  P. inhibens S4Sm is a spontaneous streptomycin-resistant (SmR) of S4 (9). It has 
strong biofilm formation capabilities and produces tropodithietic acid (TDA), which 
has been shown to be a potent antibiotic against multiple Vibrio species (9, 47). P. 
inhibens has been shown to be an effective probiotic against fish pathogen V. 
anguillarum, as well as oyster-associated pathogens V. vulnificus and V. coralliilyticus 
(9–11, 47, 48).  Probiotic activity of P. inhibens S4Sm has been previously attributed 
to TDA production, biofilm formation, and acyl homoserine production (Fig. 6) (9, 49).  
Prior research by LaPorte and Nelson showed that P. inhibens S4Sm significantly 
increased shrimp survival from V. parahaemolyticus induced AHPND compared to the 
AHPND infection control and many other probiont candidates (Fig. 7) (12). Only 
Pseudoalteromonas piscicida provided similar protection against AHPND as P. 






Figure 6. Oyster larvae survival in the presence of P. inhibens strains after challenge 
with V. coralliilyticus. The P. inhibens S4Sm strains (1 × 104 CFU/ml) were introduced 
24 h before larvae were challenged with V. coralliilyticus RE22Sm (1 × 105 CFU/ml). 
clpX mutants have normal biofilm formation but no TDA production.  exoP mutants 
produce TDA, but biofilm formation is reduced to 40% compared to wild type.  Oyster 
larvae treated only with artificial seawater served as control (mock). Oyster larvae 
survival (% ±SD) was determined 24 h after challenge with RE22Sm. Bars marked with 
an asterisk (*) show significant differences (t-test, p <0.05). Representative of at least 






Figure 7. Effect of preincubation of L. vannamei PLs with candidate probionts on 
survival 48 h after challenge with V. parahaemolyticus PSU5579Sm. PL’s were 
preincubated with P. inhibens S4Sm, Ps. piscicida JL1Sm, Ps. piscicida JL15Sm, Ps. 
arabiensis JL29Sm, B. denitrificans JL63Sm, and B. pumilus RI06-95Sm for 24 h prior 
to challenge with PSU5579Sm.  Candidate probionts were added at 106 CFU/ml at the 
start of the experiment and every 24 h thereafter. Challenge with V. 
parahaemolyticus PSU5579Sm (at 106 CFU/ml) occurred 24 h after the addition of the 
probionts. Representative of three independent experiments with three technical 
replicates per experiment.  Error bars equal one standard deviation. * Indicates 
statistically significant difference from the V. parahaemolyticus PSU5579Sm 
treatment (ANOVA, p <0.05) (12). 
 
Halobacteriovorax 
Halobacteriovorax is a genus of predatory marine bacteria within the 
Deltaproteobacteria; it was first differentiated from freshwater genus Bacteriovorax 
in 2015 (50). Currently, two named species belong to this genus: Halobacteriovorax 




characteristics with the predatory genus Bdellovibrio including its unique, two-phase 
life cycle in which it attacks a Gram-negative bacterium in its prey range, penetrates 
the cell into the periplasm and replicates inside the periplasm using the nutrients 
provided by the prey cell (52).  Organisms with this unique life cycle are often 
grouped together into a class called Bdellovibrio and Like Organisms (BALOs). It has 
been proposed that BALOs could help prevent AHPND in shrimp aquaculture (53). 
Halobacteriovorax sp. GB3 was isolated from Narragansett Bay and tested against a 
strain of AHPND-inducing Vibrio parahaemolyticus. 
 
Research Goals 
The overall goal of this research was to examine the interactions between V. 
parahaemolyticus and potential probiotic organisms that demonstrate ability to 
inhibit its growth.  The first aim was to understand the mechanisms by which the 
probiont P. inhibens S4Sm protects shrimp from V. parahaemolyticus induced 
AHPND, and how the probiont mitigates the pathogenic activity of V. 
parahaemolyticus.   
The second aim was to isolate and identify a BALO organism, which preys on 
V. parahaemolyticus, and to test its safety for use in shrimp aquaculture as a 
potential control to prevent the wide-scale growth of V. parahaemolyticus in 
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We have been investigating potential probiotic treatments for Acute 
Hepatopancreatic Necrosis Disease (AHPND), affecting farmed shrimp and caused by 
the marine pathogen Vibrio parahaemolyticus. In this study we screened over 300 
organisms for key probiotic functions, including antibiosis against the pathogen and 
biofilm formation. Twelve candidate probionts were screened using Artemia nauplii 
and post-larval Litopenaeus vannamei for the in vivo ability to protect against fatal V. 
parahaemolyticus infections.  We found that Phaeobacter inhibens, which has been 
shown to protect oysters and turbot from vibriosis with inhibitory activity against 
Vibrio coralliilyticus and Vibrio anguillarum also has potential as a preventative 
treatment for AHPND.  In infection challenges, pre-treatment with P. inhibens S4Sm 
increased the relative survival of L. vannamei post-larvae to 80% as compared to 45% 
survival in the infected control.  As identified in previous research, the mechanisms of 
P. inhibens S4Sm probiotic activity may include its ability to form robust biofilms, 
quorum sensing/quorum quenching through N-acyl homoserine lactone (AHL) 
signaling, and production of antibiotic tropodithietic acid (TDA).  In this study, we find 
that V. parahaemolyticus forms biofilms with 3 to 5-fold increased cell density when 
co-cultured with P. inhibens S4Sm as compared to a monoculture control. 
Additionally, V. parahaemolyticus is not sensitive to TDA at concentrations up to 
100 µg/ml. Mutations that disrupt biofilm formation and quorum sensing eliminate 






Statement of Significance 
In this investigation we found that while P. inhibens S4Sm protects Artemia 
nauplii and White Leg shrimp (Litopenaeus vannamei) from AHPND. However, it does 
not inhibit the growth of the pathogen, suggesting that antibiosis is not a probiotic 
mechanism of P. inhibens in preventing AHPND. Rather, probiotic activity is linked to 
N-acyl homoserine lactone (AHL) signal production and biofilm formation. The 
advantage of a probiotic that does not inhibit the growth of a pathogen is that there 
is no selective pressure for the pathogen to develop resistance to the probiont, 
making such an organism an attractive option for long-term use in the prevention of 




Shrimp aquaculture is a multi-billion dollar global industry with production 
estimated between 2.9-3.5 billion tons in 2017 with 75-80% of production in South 
East Asia (1).  The United States alone, imported $6.5 billion of shrimp in 2017, an 
increase of 14% from the year before (1). AHPND is the major cause of Early 
Mortality Syndrome, responsible for significant losses in the shrimp farming industry. 
AHPND usually begins within seven to ten days after ponds are stocked with post 




probiotics may offer a disease control strategy to reduce losses in the shrimp farming 
industry without the potentially harmful effects of wide-scale antibiotic use (3). 
Probiotics are live microorganisms that, when administered in adequate 
amounts, confer a health benefit on the host (4).  Research indicates that strong 
candidate probiotics are able to inhibit the growth of pathogens through the 
production of antibiotic compounds , biofilm formation and quorum sensing/quorum 
quenching such as through acyl homoserine lactone (AHL) signaling (5–9) to prevent 
disease.  Candidate probiotics must also be able to tolerate growth conditions 
associated with the pathogen, such as the acidity of the digestive tract or, in the case 
of shrimp aquaculture, the salinity of the environment.  Most importantly, a probiont 
must not reduce the overall health of the host organism while present in a 
concentration sufficient for preventing disease. 
In this study, we screened ten newly isolated bacteria and two oyster 
probionts, Phaeobacter inhibens S4Sm and Bacillus pumilus RI06-95, for antibiotic 
activity against an AHPND-inducing strain of V. parahaemolyticus, as well as their 
ability to protect Artemia nauplii or Litopenaeus vannamei post-larvae (PLs) from 
AHPND V. parahaemolyticus.  We found that P. inhibens S4Sm was the only candidate 
probiont that both significantly increased the survival of and did not harm either 
Artemia nauplii and L. vannamei PLs challenged with AHPND V. parahaemolyticus.  To 
understand the mechanisms by which P. inhibens S4Sm protected L. vannamei PLs 
from AHPND, we performed a series of competitive growth assays using mutant 




ionophore antibiotic tropodithietic acid (TDA), or knockout mutations in the AHL 
signaling pathways.  We also tested the ability of the mutant strains to protect PLs 
challenged with V. parahaemolyticus. 
 
Results 
Selection of an AHPND-inducing V. parahaemolyticus strain.    
Ten strains of V. parahaemolyticus, isolated from shrimp farms in southern 
Thailand during an outbreak of AHPND were screened for the presence of the priA 
and pirB genes by duplex PCR.  PCR amplification was performed using primers 
VpPirA-284F/R and VpPirB-392F/R as described by Han et al. (10).  Of these strains, 
six were identified to possess both genes (Fig. 1) and were then used to challenge 
Artemia nauplii (Fig. 2).  Strain PSU5579 exhibited the highest rate of mortality (92%) 
in Artemia nauplii and was selected for use in future experiments. All other strains 
tested appeared to be avirulent. 
 
Selection of probiotic organisms: 
More than 300 bacterial isolates were screened for probiotic activity against 
V. parahaemolyticus with a zone of inhibition (ZOI) assay.  Ten isolates produced ZOIs 
between 0.1mm and 6.4mm.  These candidate organisms that produced a zone of 
inhibition, along with the two known marine probionts P. inhibens S4Sm and B. 
pumilus RI06-95, were then evaluated for biofilm formation via crystal violet staining 




microbes produced biofilms significantly larger than the pathogen V. 
parahaemolyticus PSU5579 with optical densities between 1.3 and 3.7 at 580 nm. 
Only isolate HR-1 failed to produce copious biofilm. The oyster probiont, P. inhibens 
S4Sm, consistently produced the most abundant biofilm.  
In an effort to identify the candidate probionts, genomic DNA was extracted 
from the ten isolates for PCR amplification and sequencing of the 16S rRNA gene as 
described in the Methods. The organisms were identified (Table 1) by comparing the 
resulting 16S rDNA sequences with the NCBI bacterial ribosomal database (11).  
Seven of the isolates were found to be members of the genus Pseudoalteromonas, 
two were genus Bacillus, and one was Bowmanella. 
 
Artemia nauplii assay 
Artemia are frequently used as a model organism to test for biotoxicity in 
marine systems (12).  In this assay, Artemia were used to screen candidate probionts 
identified above for potential harmful effects in Artemia nauplii prior to their use in 
trials with L. vannamei PLs. Pseudoalteromonas strains (JL1, JL15, JL29) significantly 
decreased survival of Artemia when the Artemia nauplii were treated with 
concentrations at 1×105 CFU/ml, while Bowmanella denitrificans (JL63) did not (Fig. 
4). Artemia nauplii were then pre-treated with candidate probionts at concentrations 
ranging between 1×104 to 1×107 CFU/ml for 24 hours and then challenged with V. 
parahaemolyticus PSU5579 at 105 CFU/ml.  Potential probiotics were added every 24 




Pseudoalteromonas species (isolates GR1, GR4, JL1, JL12, JL15, JL18 and JL29) or B. 
denitrificans (isolate JL63) followed by challenge with the pathogen PSU5579 resulted 
in the complete killing of the Artemia compared to 37% survival of Artemia the 
challenged with PSU5579 alone. (Fig. 5).  When Artemia were pre-treated with B. 
pumilus strains RI06-95, JL70, and HR1 at 104, 105, or 106 CFU/ml for 24 hours and 
then challenged with V. parahaemolyticus PSU5579, there was no significant increase 
in survival 48 hours following the challenge when compared to the challenged 
control (Fig. 6).  Artemia nauplii pre-treated for 24 hours with P. inhibens S4Sm and 
then challenged V. parahaemolyticus PSU5579 showed a 1.84-fold increase (to 70%) 
in their rate of survival 48 hours post challenge when compared with the challenged 
control with survival of 38%. Pre-treated and challenged survival was similar to 
survival when treated with P. inhibens S4Sm alone. (Fig. 7). This result suggested that 
since P. inhibens S4Sm was not harmful to Artemia and was able to reduce AHPND 
mortalities in Artemia challenged with V. parahaemolyticus PSU5579, it should be an 
excellent candidate probiont for L. vannamei. 
Shrimp trials   
In initial trials to examine the safety of the candidate probionts, L. vannamei 
PLs were treated with candidate probionts at 106 CFU/ml every 24 hours for 72 hours 
and survivors were counted. Most strains tested did not significantly decrease 
survival of shrimp PLs; however, P. piscicida JL1 significantly decreased survival to 
83% compared to 97% survival in the untreated control (Fig. 8).  To test the efficacy 




challenged at 24 hours with V. parahaemolyticus PSU5579 at 106 CFU/ml.  They were 
followed for 48 hours post-challenge and survivors were counted.  Shrimp treated 
with either P. inhibens S4Sm or P. piscicida JL1 showed significant protection against 
AHPND when compared to the challenged control (Fig. 9); however, since JL1-treated 
shrimp exhibited decreased survival even when not challenged with PSU5579, S4Sm 
was selected as the best candidate probiont.   
A series of experiments were performed to determine which probiotic 
characteristics of P. inhibens S4 were critical to protecting L. vannamei from V. 
parahaemolyticus PSU5579.  These trials were altered from the original experimental 
design to prevent the L. vannamei microbiome from confounding experimental 
results.   In this set of experiments, bottles containing 200 ml 3% artificial sea water 
(ASW) plus P. inhibens wild type or mutant strains at a concentration of ~106 CFU/ml 
were allowed to incubate for 24 hours at 29oC.  Shrimp were added to the bottles 
after 24 hours and immediately challenged with V. parahaemolyticus PSU5579 at 106 
CFU/ml.  P. inhibens treatments were repeated every 24 hours and survivors were 
counted 48 hours post-challenge.  The relative rates of survival for shrimp treated 
with wild type P. inhibens S4SmKm, or the clpX (WZ10) mutant strain (no TDA 
production) or the luxO (CS003) mutant (over-produces TDA) were the same (76.5 % 
to 80%).   In contrast, the relative rates of survival for shrimp treated with the exoP 
(WZ20) mutant strain (reduced biofilm formation; 51.5%), or pgaI mutant strain 
(lacking biofilm, TDA production and AHL signal production; 59%), or the pgaR 




not significantly different from the 45% survival rate in PSU5579 challenged control 
shrimp (Fig. 10). We did not test revertants or complements of these mutant strains; 
however, Zhao et al (6) found that complementation of the clpX and exoP genes in 
mutant strains restored function to wild type levels. These data strongly suggest that 
biofilm formation and quorum signaling are necessary for the probiotic activity of P. 
inhibens S4Sm, while TDA production is not necessary. 
             
Competitive biofilm assays 
In an effort to understand the competition between pathogen (PSU5579) and 
probiont (S4Sm), we used a modification the glass coverslip assay developed by Zhao 
et al (6). We found that P. inhibens S4SmKm did not inhibit the biofilm formation of 
V. parahaemolyticus PSU5579 when the two organisms were co-cultured (Fig. 11). In 
fact, at all times the biofilm cell density of PSU5579 in co-culture with S4SmKm was 
increased compared to the PSU5579 monoculture biofilm. The increases in biofilm 
were 5.5-fold at 24 h, 3-fold at 48 h, and 3.7-fold at 72 h. The biofilm density of S4Sm 
was not affected by co-culture.  This contrasts with the probiotic activity of P. 
inhibens S4Sm against other Vibrio species, where pathogen biofilm cell density was 
decreased when in co-culture (6).   
Mutant strains of P. inhibens S4SmKm (clpX, luxO, or pgaI) were tested for 
their ability to affect either biofilm formation or planktonic cell density of V. 
parahaemolyticus PSU5579. Co-culture of PSU5579 with any of the three mutants 




V. parahaemolyticus PSU5579 was not reduced when grown in co-culture with any of 




Since the ability of P. inhibens to provide protection against V. 
parahaemolyticus PSU5579 was not affected by their ability to produce TDA, we 
wanted to determine the minimum inhibitory concentration (MIC) of TDA against V. 
parahaemolyticus PSU5579. Briefly, V. parahaemolyticus PSU5579 (initial density 105 
CFU/ml) was grown in mLB30 (27°C, 24 h) in the presence of different concentrations 
of TDA plus two controls, one containing 1% DMSO, (the solvent in which TDA is 
dissolved) and one without additions. Cell density was determined by serial dilution 
and spot plating. Vibrio coralliilyticus RE22 and Vibrio anguillarum NB10Sm are 
inhibited at 6.25 µg/ml and 1.25 µg/ml, respectively (6). In contrast, V. 
parahaemolyticus PSU5579 growth was not inhibited by TDA at concentrations up to 
100 μg/ml. These data demonstrate that TDA production does not inhibit V. 
parahaemolyticus PSU5579 growth. 
 
Discussion: 
In this study we screened more than 300 isolates for probiotic activity.  First, 
we examined antibiosis using a ZOI assay.  Antibiosis is considered one the of the key 




host environment through competitive advantage and also to fend off potential 
pathogens (13).  Next we considered biofilm formation. A biofilm is an assemblage of 
microbial cells that is associated with a surface and enclosed in a matrix of primarily 
polysaccharide material (14).  Formation of dense biofilms by probiotics is considered 
protective because it allows the probiont to establish long-lasting colonization of the 
host and prevent colonization by pathogens (15). In some strains of Lactobacilli, it has 
been observed that the exopolysaccharide (EPS), which binds the bacteria to a 
surface, can also prevent biofilm formation by pathogens (15). The aquatic 
environment allows for the possibility that colonization of the environment may be 
an effective alternative to probiotic colonization of the gut (16). Perhaps the most 
important feature of a probiotic treatment is that it not cause harm to the host (17). 
After completing challenge assays in both Artemia nauplii and shrimp PLs, a single 
organism met all these criteria.  P. inhibens S4Sm produces the potent antibiotic TDA, 
forms the most robust biofilms of the twelve organisms selected for trials, and it did 
not cause significant harm for either model organism when used as a 
monotreatment.  Specifically, P. inhibens S4Sm had no negative effects on L. 
vannamei and had the least negative effect (decline of ~15%) on Artemia compared 
to all other candidates tested. 
In challenge assays, we found that P. inhibens S4Sm protects Artemia nauplii 
and L. vannamei from the pathogen V. parahaemolyticus PSU5579.  Zhao et al (6, 18) 
identified three key characteristics in P. inhibens S4Sm’s ability to protect against V. 




signaling); however, these functions are not equally important in all systems.  V. 
anguillarum is highly sensitive to TDA, at concentrations as low as 1.25 µg/ml (6), but 
the disruption of AHL signaling has little impact on the inhibitory activity of 
Phaeobacter gallaenciensis against this fish pathogen (19).  In contrast, V. 
coralliilyticus is less sensitive to TDA at 6.25 µg/ml (6); however, AHL signaling plays a 
significant role in the downregulation of virulence factors, and is a component critical 
to the protective functions of P. inhibens S4Sm against this oyster pathogen (18).  
Upon identifying P. inhibens S4Sm as a candidate probiotic to protect shrimp 
from AHPND, we investigated these three probiotic functions to determine which 
were critical to protect shrimp against the pathogenic activity of V. 
parahaemolyticus.   Our data suggest that the reduction of quorum 
sensing/quenching signaling through mutation of the AHL synthase (pgaI) or 
transcriptional activation/response regulation (pgaR) or reduced AHL concentration 
due to decreased biofilm formation (exoP) decreases the probiotic function of P. 
inhibens S4Sm.  P. inhibens S4Sm mutant strains CS001 (DpgaI) and CS002 (DpgaR) 
did not provide significant protection of PLs when compared to the infected control 
(Fig. 10).  These mutant strains together encode for a luxIR homologous AHL 
mediated quorum sensing system.  The pgaI gene encodes for the N-3-
hydroxydecanoylhomoserine lactone (3-OH C(10)-HSL) synthase and, therefore, a 
mutation in this gene disrupts AHL production.  pgaR encodes for the AHL response 
regulator. While this mutant can produce the AHL signal, it does not engage in the 




cells (20). Cell to cell signaling and biofilm formation are intricately connected (21). In 
general, cells in biofilms encounter much higher local cell densities, and therefore 
higher concentrations of AHL signals than free-floating planktonic cells (22); as a 
result, the disruption of the pgaIR system also reduces biofilm formation.  Likewise 
the DexoP mutant WZ20, which has 40% or less of the biofilm formation of wild type 
cells (6) also has decreased AHL activity due to the reduced localized cell 
concentration.  WZ20 does not, however, have reduced TDA activity and Zhao et al 
(6) found it had delayed inhibitory activity against TDA-sensitive Vibrio species. Given 
the common features of these three mutant strains, which are the interconnected 
functions of AHL signaling and biofilm formation, and their shared inability to protect 
shrimp from AHPND, we conclude that AHL signaling and biofilm formation are 
critical to the probiotic activity of P. inhibens S4Sm in protecting shrimp.  As Zhao et 
al (18) showed that the AHL activity of P. inhibens S4Sm downregulates virulence 
factors in V. coralliilyticus RE22, we propose studying the effects of AHL signaling 
upon the regulation of AHPND related virulence factors.  
Having explored the functions of AHL signaling and biofilm formation, the 
remaining known probiotic feature of P. inhibens S4Sm is the production of the 
antibiotic ionophore, TDA.  In contrast to the effects of P. inhibens on the oyster and 
fish pathogens (Alliiroseovarius crassostreae, V. coralliilyticus, and V. anguillarum) (6, 
23–25), the growth of V. parahaemolyticus PSU5579 is not inhibited by either P. 
inhibens S4Sm or pure TDA.  The negative results of both the TDA growth inhibition 




resistant to TDA produced by P. inhibens S4Sm.  This observation is notable for two 
reasons.  First, because P. inhibens S4Sm does not inhibit the growth of PSU5579, it is 
potentially an excellent probiotic for long-term use in shrimp aquaculture as there is 
no selective pressure for the pathogen to develop resistance to the probiotic 
mechanisms of P. inhibens.  In fact, competition assay data suggest these two 
organisms are mutualistic, growing as well, if not better when co-cultured in biofilms 
(Fig. 11).  Second, naturally occurring resistance to TDA has not previously been 
observed outside the Roseobacter genus (26, 27).  This unexpected result suggests 
that P. inhibens S4Sm is a particularly strong candidate as a probiotic, because, 
without growth inhibition, there is no selective advantage for V. parahaemolyticus 




Materials and Methods: 
Bacterial strains and culture conditions 
Bacterial species and strains used in this study are listed in Table 1. All 
bacteria were grown at 27°C with shaking.  P. inhibens S4Sm wild type and mutant 
strains were routinely grown to stationary phase in marine yeast peptone 30 (mYP30; 5 
g/L peptone, 1 g/L yeast extract, 30 g/L Instant Ocean®, pH7.5) for 48 h. V. 
parahaemolyticus PSU5579Sm was grown to stationary phase in LB30 (10 g/L 





Duplex PCR for the detection of pirA- and pirB genes 
  Ten strains of V. parahaemolyticus isolated from shrimp farms in the Pattani 
and Songkla provinces of southern Thailand during an AHPND outbreak were 
screened for the presence of the pirA- and pirB genes.  The V. parahaemolyticus 
strains were gifted by Dr. John Mekalanos (Harvard Medical School).  Genomic DNA 
was isolated using the Bio Basic EZ-10 Spin Column Bacterial Genomic DNA Miniprep 
Kit.  Primers VpPirA-284F (5’-TGACTATTCTCACGATTGGACTGR-3’), VpPirA-284R (5’-
CACGACTAGCGCCATTGTTA-3’), VpPirB-392F (5’-TGATGAAGTGATGGGTGCTC-3’), and 
VpPirB-392R (5’-TGTAAGCGCCGTTTAACTCA-3’) were used to amplify the pirA- and 
pirB genes (10).  1 µl of extracted gDNA (10-60 ng/µl) was combined with 1 µl of each 
primer (10 µmol), 7.5 µl nuclease-free water, and 12.5 µl of QIAGEN Taq PCR master 
mix.  Reaction conditions were 94 °C for 3 min, followed by 35 cycles of 94 °C for 30 s, 
60 °C for 30 s, and 72 °C for 30 s; and a final extension at 72 °C for 7 min.  PCR 
products were separated on a 2% agarose gel containing ethidium bromide (0.4 
µg/ml) and visualized on a UV transilluminator.  Presence of pirA is indicated by a 
band at 284 bp, while presence of pirB is indicated by a band at 392 bp (28). 
 
16S rRNA gene sequencing 
  Genomic DNA was isolated using the Bio Basic EZ-10 Spin Column Bacterial 
Genomic DNA Miniprep Kit.  Primers 27F (5’-AGAGTTTGATCCTGGCTCAG-3’) and 
1525R (5’-AAGGAGGTGWTCCARCC-3’) were used to amplify the 16S rRNA gene (11).  




each primer (stock solution, 10 µmol), 9.5 µl nuclease-free water, and 12.5 µl of 
QIAGEN Taq PCR master mix.  Reaction conditions were 95 °C for 2 min, followed by 
35 cycles of 94 °C for 15 s, 53 °C for 30 s, and 72 °C for 1.5 min; and a final extension 
at 72 °C for 5 min.  PCR products were sequenced at the University of Rhode Island 
Genomics and Sequencing Center.  Sequences were compared to the National Center 
for Biotechnology Information (NCBI) database of bacterial genomes using nucleotide 
to nucleotide basic local alignment search tool (blastn) 
 
Zone of inhibition assay:   
V. parahaemolyticus PSU5579Sm was grown for 24 h in mLB30, diluted 100-fold, and 
100 µl of the diluted culture was spread on mYP30 agar (YP30 + 1.6% Bacto 
Agar).  The inoculated agar plates were allowed to dry for 5-15 min and then 
candidate probiotic cultures (grown to stationary phase) were spotted onto the 
plates (10 µl/spot).  Plates were incubated at 27 °C for 24-48 h. Zones of inhibition, 
defined as the distance between the growth of the probiotic organism and the lawn 
of V. parahaemolyticus, were measured in mm (28). 
 
Biofilm assay 
Biofilm formation was quantified using a modification of the crystal violet 
staining method (6).  Bacteria were grown for 24 h before being diluted 103-fold into 
200 µl of mYP30 in a polystyrene 96-well plate which was then incubated at 27 °C for 




stained with 0.2% crystal violet for 20 min, washed twice with ASW, and biofilm-
bound crystal violet was eluted with 95% ethanol for 30 min before being measured 
at OD580.  Each candidate probiont was tested in three wells per experiment and each 
experiment was repeated twice.  
  
Artemia nauplii challenge 
Artemia cysts (0.075 g) were hatched in an inverted 60 ml syringe, covered 
with perforated plastic wrap, containing 60 ml HEPPS-buffered (10 mM, pH 8.2) 
sterile ASW at 28 °C for 24 h with constant aeration and fluorescent light.  To 
maintain pH and maximize Artemia hatching rate, an increased buffer capacity is 
required to avoid a drop in the pH due to the acid produced by cysts during hatching 
(29).  Hatched nauplii (2 ml, containing approximately 400 nauplii) were transferred 
to 50 ml centrifuge tubes containing 26.3 ml HEPPS-buffered (10 mM, pH 8.2) 
ASW.  Nauplii were fed autoclaved Escherichia coli K-12 cells at a final concentration 
of 107 cells/ml during hatching and every 24 h.  Candidate probionts were washed 
twice in sterile ASW by centrifugation at 6,000 × g for ten minutes at 4 °C.  Nauplii 
were treated with candidate probionts after hatching and every 24 h.  The centrifuge 
tubes were placed in a rotator set to 4 rpm at 30 °C. After incubation for 24 h, 1.6 ml 
mYP30 was added to each tube and nauplii were challenged with 1×105 CFU/ml 
washed V. parahaemolyticus cells.  V. parahaemolyticus cells were washed twice in 
sterile ASW by centrifugation at 5,000 × g for five minutes at room temperature.  To 




of the nauplii suspension was transferred into each well of a tri-well petri dish 
containing 5 ml of ASW with 0.05% agar (to slow nauplii movement during counting), 
and nauplii were viewed under a dissecting microscope.  Nauplii were counted at 24 
h and 72 h to quantify survival. Nauplii which showed any signs of movement were 
counted as alive. Each treatment was tested in three tubes and was repeated twice. 
Water in each tube was not changed during the experiment. 
 
White leg shrimp (L. vannamei) post-larvae challenge:  
L. vannamei post-larvae (PL) were purchased from Miami-Aquaculture 
(Boynton Beach, Florida) and maintained in 3% ASW in a 20L aquarium tank with 
filtration and weekly water changes.  PLs were fed Hagen® Fluval® Shrimp Granules 
daily.  PLs were transferred to 250 ml glass bottles with 200 mL 3% ASW and 
provided aeration through air stones.  PLs were pre-treated with potential probionts 
at 106 CFU/ml every 24 hours.  After the initial 24 h incubation, PLs were challenged 
with V. parahaemolyticus cells at a concentration of 106 CFU/ml, which were grown 
for 24 h in mLB30 and harvested by centrifugation (6,000 x g, 5 min, 4C), and washed 
twice in ASW.  PLs were incubated at 29 °C and survivors were counted at 24, 48 and 
72 h time points (28). 
 
Competitive Biofilm assay:  
The competitive biofilm assay was carried out using a modification of the 




mL of mYP30 in tri-well plates containing UV sterilized glass coverslips at a 
concentration of 104 CFU/mL, and incubated at 27 °C for 24 h.  After 24 h the 
coverslips were removed, washed in sterile 3% artificial seawater and placed into 
fresh mYP30 in a new tri-well plate.  At this time, V. parahaemolyticus PSU5579Sm 
was added at a concentration of 105 CFU/ml.  A cover slip was removed each 
subsequent 24 h period, washed in 3% ASW and vortexed for 2 minutes with sterile 
glass beads to remove the biofilm. This mixture was serially diluted and spot plated 
(10 μl/spot) on mYP30 agar plates to determine concentration in CFU/cover slip. The 
supernatant was sampled at the same time to determine planktonic cell 
concentration of both organisms using serial dilution and differential media to plate 
and count CFU/ml.   Samples were taken for up to 96 hours to track the changes in 
planktonic and biofilm cell concentrations (6). 
 
Minimum Inhibitory Concentration Assay: 
The minimal inhibitory concentrations (MIC) of TDA against V. 
parahaemolyticus was assessed using a broth dilution method in microtiter 
plates.  Overnight bacterial cultures were diluted to 105 CFU/ml in LB30 and treated 
with serial dilutions of pure TDA. After 24 h incubation at 27 °C, growth was assessed 
using OD600 and serial dilution with spot plating to determine CFU/ml. Three 
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Table 1. Bacterial Strains used  
Strain Origin Characteristics Reference 
Phaeobacter inhibens S4Sm  Healthy oyster Spontaneous SmR, [1] 
Phaeobacter inhibens 
S4SmKm CS4KN  
 Harboring pSUP203 Kmr C. 
Schuttert 









Reduced Biofilm formation [1] 




No TDA production, no biofilm 















Increased TDA production C. 
Schuttert 




Spontaneous SmR (28) 
Bacillus pumilus RI06-95 Marine 
Sponge 
    
Pseudoalteromonas 
piscicida GR1 
Seawater   This study 
Pseudoalteromonas 
flavipulchra GR4 
Seawater   This study 
Pseudoalteromnas piscicida 
JL1 
Seawater   This study 
Pseudoalteromonas 
piscicida JL12 




Brine Shrimp   This study 
Pseudoalteromonas 
flavipulchra JL18 













  This 
Study 
Bacillus pumilus JL70 Gulf Shrimp 
intestines 
  This 
Study 









Figure 1. Detection of pirA- and pirB-like genes found on the pVPA3-1 plasmid. 
Imaged on a 2% agarose gel with ethidium bromide (0.4 µg/ml). PCR amplification 
was performed using primers VpPirA-284F/R and VpPirB-392F/R as described by Han 
et al. (10).  A band at 284 bp indicates a pirA, while presence of a pirB amplicon is 








Figure 2. Survival rates of Artemia nauplii when treated with V. parahaemolyticus at 
105 CFU/ml 24 hours after hatching.  Strain PUS5579 caused the highest mortality 































Figure 3.  Biofilm formation quantified by the crystal violet method.  Cultures were 
grown in 96-well plates for 24 hours at 27 °C.  Biofilms in the wells were washed with 
ASW, stained with 0.2% crystal violet, washed again, and biofilm-bound crystal violet 
was eluted using 95% ethanol and then optical density at 580 nm was measured.  
These data are an average of three biological replicates with three technical 
replicates per experiment.  Error bars equal one standard deviation.  * Indicates 























































 Figure 4. Artemia nauplii survival when treated with Pseudoalteromonas strains 
alone at 105 CFU/ml daily for 72 h.  These data are an average of three biological 
replicates with three technical replicates per experiment.  Error bars equal one 
standard deviation. * Indicates statistically significant difference from the Control 



























Figure 5. Pseudoalteromonas and Bowmanella strains decreased Artemia nauplii 
survival when pretreated for 24 hours at 104 CFU/ml and then challenged with 
PSU5579 at 105 CFU/ml.  Error bars equal one standard deviation. These data are an 
average of three biological replicates with three technical replicates per experiment. 




































































 Figure 6. B. pumilus strains did not improve survival of Artemia nauplii. Artemia were 
pre-treated with B. pumilus at concentrations of 104 CFU/ml (1E4), 105 CFU/ml (1E5), 
or 106 CFU/ml (1E6) and then challenged with V. parahaemolyticus PSU5579 at 105 
CFU/ml. Candidate probionts were added every 24 hours and survivors were counted 
at 48 hours. These data are an average of three biological replicates with three 







 Figure 7.   Pre-treatment of Artemia with P. inhibens S4Sm improves survival.   
Artemia  were pre-treated with P. inhibens S4Sm at 106 CFU/ml for 24 h improves 
survival 48 h after challenge with V. parahaemolyticus PSU5579 at 105 CFU/ml.  P. 
inhibens S4Sm was added at the start of the experiment and every 24 h.  These data 
are an average of three biological replicates with three technical replicates per 
experiment.  Error bars equal one standard deviation.  Different letters indicate 







Figure 8.  L. vannamei PL survival when treated with probiotic strains alone at 106 
CFU/ml daily for 72 h. These data are an average of three independent experiments 
with three technical replicates per experiment.  Error bars equal one standard 






























Figure 9.  P. inhibens S4Sm and P. piscicida JL1Sm provide significant protection to L. 
vannamei PLs. When L. vannamei PLs were pre-treated with P. inhibens S4Sm and P. 
piscicida JL1Sm at 106 CFU/ml and challenged with V. parahaemolyticus PSU5579 at 
106 CFU/ml after 24 hours. These data are an average of three biological replicates 
with three technical replicates per experiment.  Error bars equal one standard 
deviation. * Indicates statistically significant difference from the challenged control 



































































Figure 10: Relative shrimp survival when environment was pre-treated with P. 
inhibens S4smkm and mutant strains of P. inhibens S4. Shrimp were added at 24 
hours and challenged with V. parahaemolyticus PSU5579.  These data are an average 
of three biological replicates with three technical replicates per experiment.  Error 
bars equal one standard deviation. * Indicates statistically significant difference from 
the uninoculated control shrimp (ANOVA, p<0.05).  
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Figure 11.  Biofilm formation by V. parahaemolyticus PSU5579 and P. inhibens 
S4SmKm is not inhibited during co-culture.  These data are a log-transformed average 
of at least four biological replicates with three technical replicates per experiment.  


































Figure 12  
Figure 12. The effects of co-culture of V. parahaemolyticus PSU5579 with P. inhibens 
S4SmKm wild type (grey) or mutants (luxO (light blue), clpX (green), or pgaR (dark 
blue)) on PSU5579 biofilm (panel a) or planktonic (panel b) cell densities. Biofilm or 
planktonic cell density for the V. parahaemolyticus PSU5579 only control is shown in 
yellow. Time points represent the time after the start of the experiment (addition of 
P. inhibens cells, 104 CFU/ml)). V. parahaemolyticus cells were added (105 CFU/ml) at 

























































Figure 13. Growth of V. parahaemolyticus PSU5579 in LB30 containing various 
concentrations of TDA. Cells were inoculated at an initial concentration of 1×105 
CFU/ml  and incubated at 27°C  for 24 h. Final cell densities were determined by 
serial dilution and plating. Data are a log-transformed average of two biological 
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The daft genome of Halobacteriovorax sp. GB3, isolated after enrichment on 
the Acute Hepatopancreatic Necrosis Disease (AHPND)-inducing Vibrio 
parahaemolyticus PSU5579, is presented.  The 3.62-Mbp genome of this predatory 
bacterium contains 3493 coding sequences. Sequence comparisons between 15 
different proteins suggest that this represents a new species of Halobacteriovorax. 
 
Body 
Halobacteriovorax, a genus of marine Bdellovibrio and like organisms (BALOs) 
within the Deltaproteobacteria, was first differentiated from freshwater 
Bacteriovorax in 2015 (1). Currently, two named species belong to this genus: 
Halobacteriovorax litoralis and Halobacteriovorax marinus (1, 2). It has been 
proposed that BALOs could help prevent AHPND in shrimp aquaculture (3). 
Halobacteriovorax sp. GB3 was isolated from Narragansett Bay after enrichment on a 
strain of AHPND-inducing Vibrio parahaemolyticus.  Sea water was filtered through a 
0.45 μm filter to remove sediments and larger organisms.  The filtrate was added to 
nutrient-free soft agar containing 106 CFU/ml V. parahaemolyticus PSU5579 and 
poured onto mYP30 (5 g/L peptone, 1 g/L yeast extract, 30 g/L Instant Ocean®, pH7.5) 
+ 1.5% agar plates. Plates were observed for plaque formation after 5 days 
incubation at 27oC.  Picked plaques were added to stationary phase cultures of V. 




30 g/L Instant Ocean®, pH7). This process was repeated; co-cultures were visualized 
by microscopy to determine if contamination was present.  After 7 passes through 
the plaque process, the co-cultures were centrifuged at 6,000 ´ g for 5 minutes at 
4°C and the supernatant filtered through a 0.22 μm filter. Filtrate was added to a 
stationary phase culture of V. parahaemolyticus PSU5579 and grown shaking at 27°C.  
After 24 hours the co-culture was observed to be contaminant-free via microscopy. 
 
Genomic DNA was isolated using Promega’s Wizard genomic DNA purification 
kit. Halobacteriovorax sp. GB3 was grown shaking overnight at 27°C in a stationary 
phase culture of V. parahaemolyticus in mLB30 broth.  Cultures were centrifuged for 
5 minutes at 6,000 ´ g; supernatant was filtered through a 0.22 μm filter to remove 
prey cells.  Isolated DNA was resuspended in 2 mM Tris-HCl buffer (Bio Basic).  
Sequencing was performed at the Rhode Island Genomics and Sequencing Center 
using an Illumina MiSeq Sequencer.  Sequence trimming and de novo assembly was 
performed using CLC Genomics Workbench (version 12). The resulting contigs were 
processed using CLC Microbial Genome Finishing module.  The draft genome contains 
9 contigs, with a total sequence length of 3,622,901 bp and 36.9% GC content. Gene 
annotation was performed using Rapid Annotations using Subsystems Technology 
(RAST) resulting in 3493 coding sequences and 39 RNAs (4).  227 SEED subsystems 
were identified containing 19% of the coding sequences (5).   
The 16S rRNA gene was PCR-amplified from genomic DNA using16S primers 




Comparison using the National Center of Biotechnology Information (NCBI) Basic 
Local Alignment Search Tool (BLAST), determined the 16S rRNA gene of 
Halobacteriovorax sp. GB3 shares 93.47% nucleotide identity with H. litoralis JS5, and 
92.87% identity with H. marinus BE01and H. marinus SJ respectively.  A RAST 
comparison of 15 conserved genes revealed Halobacteriovorax sp. GB3 shares an 
average of 80.6% amino acid identity with H. marinus BE01 and H. marinus SJ, 
whereas the two H. marinus species are 100% identical across these genes (Table 2).  
For these reasons, we propose that Halobacteriovorax sp. GB3 is a novel species.   
 
Accession number(s). The draft genome of Halobacteriovorax sp. GB3 has been 
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Table 1. Bacterial strains compared using BLAST analysis 
STRAIN NAME REFERNENCE 
HALOBACTERIOVORAX MARINUS BE01 (7) 
 
HALOBACTERIOVORAX MARINUS SJ (8) 
 
HALOBACTERIOVORAX SP.  BALO_7 (9) 
 
HALOBACTERIOVORAX SP.  GB3 This Study 
 
 
Table 2.  Comparison of conserved genes 














subunit E  
  
91.13 91.13 90.15 100 88.67 
NADH-ubiquinone 
oxidoreductase chain B 
 




93.04 93.04 91.04 100 91.62 
LSU ribosomal protein 
 L14p  
  
92.62 92.62 92.62 100 88.52 
LSU ribosomal protein  
L16p  
  
91.11 91.11 95.62 100 88.97 
SSU ribosomal protein 
 S10p  
  



















95.77 95.77 95 100 94.23 
DNA-directed RNA 
polymerase omega 
subunit   
91.43 91.43 90 100 88.57 
SSU ribosomal protein  
S12p  
  
94.35 94.35 91.94 100 92.74 




86.11 86.11 81.03 100 79.69 
DNA polymerase III beta 
subunit  
  
67.92 67.92 61.99 100 60.38 
RecA protein 
  
81.77 81.77 84.12 100 82.02 
Chaperone protein DnaK 
  
33.21 33.21 33.21 100 86.53 
Heat shock protein GroEL 
  
88.83 88.83 86.36 100 83.52 
DNA gyrase subunit A  82.68 82.68 79.29 100 78.64 
 
 
 
 
 
 
